{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:43:08Z","timestamp":1790800988471,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-01330"],"award-info":[{"award-number":["2017-01330"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2016-01675"],"award-info":[{"award-number":["2016-01675"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.01227","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T13:30:01Z","timestamp":1561037401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds"],"prefix":"10.3389","volume":"10","author":[{"given":"Kamal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gallazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald H.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjwal","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"ref1","volume-title":"Toronto, ON, Canada: Advanced Chemistry Devlopment, Inc","year":"2017"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.virol.2014.02.004","article-title":"HIV-1 uncoating: connection to nuclear entry and regulation by host proteins","author":"Ambrose","year":"2014","journal-title":"Virology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","year":"2017","journal-title":"Lancet HIV"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1073\/pnas.1419945112","article-title":"Structural basis of HIV-1 capsid recognition by PF74 and CPSF6","volume":"111","author":"Bhattacharya","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e1001220","DOI":"10.1371\/journal.ppat.1001220","article-title":"HIV capsid is a tractable target for small molecule therapeutic intervention","volume":"6","author":"Blair","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.virusres.2012.06.016","article-title":"Molecular recognition in the human immunodeficiency virus capsid and antiviral design","volume":"169","author":"Bocanegra","year":"2012","journal-title":"Virus Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/COH.0000000000000472","article-title":"Inhibitors of the HIV-1 capsid, a target of opportunity","volume":"13","author":"Carnes","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12977-016-0262-0","article-title":"HIV-1 capsid is involved in post-nuclear entry steps","volume":"13","author":"Chen","year":"2016","journal-title":"Retrovirology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bmc.2010.11.045","article-title":"Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid","volume":"19","author":"Curreli","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bmcl.2010.10.131","article-title":"Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly","volume":"21","author":"Fader","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.chom.2018.03.009","article-title":"Single HIV-1 imaging reveals progression of infection through CA-dependent steps of docking at the nuclear pore, uncoating, and nuclear transport","volume":"23","author":"Francis","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0092-8674(00)81823-1","article-title":"Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid","volume":"87","author":"Gamble","year":"1996","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jcc.21366","article-title":"How to obtain statistically converged MM\/GBSA results","volume":"31","author":"Genheden","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.aaa5936","article-title":"X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability","volume":"349","author":"Gres","year":"2015","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.12688\/f1000research.9247.1","article-title":"Ending the HIV\/AIDS epidemic in low- and middle-income countries by 2030: is it possible?","volume":"5","author":"Harries","year":"2016","journal-title":"F1000Res"},{"key":"ref17","first-page":"23","article-title":"Conquering HIV's capsid","volume":"95","author":"Jarvis","year":"2017","journal-title":"Chem. Eng. News"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molstruc.2014.03.009","article-title":"MicroScale thermophoresis: interaction analysis and beyond","volume":"1077","author":"Jerabek-Willemsen","year":"2014","journal-title":"J. Mol. Struct."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jmb.2007.07.070","article-title":"Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein","volume":"373","author":"Kelly","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1128\/JVI.05006-11","article-title":"Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid","volume":"86","author":"Kortagere","year":"2012","journal-title":"J. Virol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1021\/ci500437r","article-title":"Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication","volume":"54","author":"Kortagere","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1128\/AAC.00985-13","article-title":"Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes","volume":"57","author":"Lamorte","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1107\/S0907444913006409","article-title":"A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization","volume":"69","author":"Lemke","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1128\/JVI.00493-12","article-title":"Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein","volume":"86","author":"Lemke","year":"2012","journal-title":"J. Virol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1742-4690-10-126","article-title":"Functional conservation of HIV-1 Gag: implications for rational drug design","volume":"10","author":"Li","year":"2013","journal-title":"Retrovirology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","article-title":"Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy","volume":"28","author":"May","year":"2014","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1093\/jac\/dkx208","article-title":"Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients","volume":"72","author":"Perrier","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2009.04.063","article-title":"X-ray structures of the hexameric building block of the HIV capsid","volume":"137","author":"Pornillos","year":"2009","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature09640","article-title":"Atomic-level modelling of the HIV capsid","volume":"469","author":"Pornillos","year":"2011","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jmb.2011.03.074","article-title":"New approaches for antiviral targeting of HIV assembly","volume":"410","author":"Prevelige","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e1002896","DOI":"10.1371\/journal.ppat.1002896","article-title":"CPSF6 defines a conserved capsid interface that modulates HIV-1 replication","volume":"8","author":"Price","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e1004459","DOI":"10.1371\/journal.ppat.1004459","article-title":"Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly","volume":"10","author":"Price","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/01.aids.0000327510.68503.e8","article-title":"HIV epidemiology and the effects of antiviral therapy on long-term consequences","volume":"22","author":"Quinn","year":"2008","journal-title":"AIDS"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1741-7015-11-251","article-title":"Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?","volume":"11","author":"Sabin","year":"2013","journal-title":"BMC Med."},{"key":"ref35","article-title":"Safety and pK of subcutaneous GS-6207, a novel HIV-1 capsid inhibitor (Abstract #141)","volume-title":"Conference on Retroviruses and Opportunistic Infections, March 4\u20137, Seattle, WA, USA","author":"Sager","year":"2019"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e1002439","DOI":"10.1371\/journal.ppat.1002439","article-title":"HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency","volume":"7","author":"Schaller","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1128\/JVI.01411-14","article-title":"Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor","volume":"89","author":"Shi","year":"2015","journal-title":"J. Virol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nsmb964","article-title":"A peptide inhibitor of HIV-1 assembly in vitro","volume":"12","author":"Sticht","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0022-2836(03)00289-4","article-title":"Antiviral inhibition of the HIV-1 capsid protein","volume":"327","author":"Tang","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nsmb967","article-title":"The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor","volume":"12","author":"Ternois","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/AAC.02574-15","article-title":"Ebselen, a small-molecule capsid inhibitor of HIV-1 replication","volume":"60","author":"Thenin-Houssier","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1016\/j.bmcl.2012.10.034","article-title":"Inhibition of HIV-1 capsid assembly: optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold","volume":"22","author":"Tremblay","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref46","article-title":"Discovery of novel potent HIV capsid inhibitors with long-acting potential","volume-title":"Conference on Retroviruses and Opportunistic Infections","author":"Tse","year":"2017"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"39314","DOI":"10.1074\/jbc.M110.155275","article-title":"Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein","volume":"285","author":"Vozzolo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1742-4690-10-136","article-title":"Dual-acting stapled peptides target both HIV-1 entry and assembly","volume":"10","author":"Zhang","year":"2013","journal-title":"Retrovirology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1093\/ofid\/ofy210.548","article-title":"539. GS-CA2: a novel, potent, and selective first-in-class inhibitor of HIV-1 capsid function displays nonclinical pharmacokinetics supporting long-acting potential in humans","volume":"5","author":"Zheng","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"9068","DOI":"10.1128\/JVI.00340-15","article-title":"HIV-1 resistance to the capsid-targeting inhibitor PF74 results in altered dependence on host factors required for virus nuclear entry","volume":"89","author":"Zhou","year":"2015","journal-title":"J. Virol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.01227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T02:38:17Z","timestamp":1569292697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.01227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":50,"alternative-id":["10.3389\/fmicb.2019.01227"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.01227","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"article-number":"1227"}}